Currently, there are 472.70M common shares owned by the public and among those 453.19M shares have been available to trade.
However, the script later moved the day high at 42.52, down -1.56%. The company’s stock has a 5-day price change of 12.97% and 37.65% over the past three months. DKNG shares are trading 33.90% year to date (YTD), with the 12-month market performance up to 168.03% higher. It has a 12-month low price of $17.12 and touched a high of $48.90 over the same period. DKNG has an average intraday trading volume of 11.84 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 10.11%, 15.17%, and 41.42% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of DraftKings Inc. (NASDAQ: DKNG) shares accounts for 67.93% of the company’s 472.70M shares outstanding.
It has a market capitalization of $22.35B and a beta (3y monthly) value of 1.86. The earnings-per-share (ttm) stands at -$1.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.52% over the week and 3.86% over the month.
Earnings per share for the fiscal year are expected to increase by 92.25%, and 659.17% over the next financial year.
Looking at the support for the DKNG, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on February 28, 2024, with the firm’s price target at $40-$49. Barclays coverage for the DraftKings Inc. (DKNG) stock in a research note released on February 23, 2024 offered a Overweight rating with a price target of $50. Oppenheimer was of a view on February 20, 2024 that the stock is Outperform, while Needham gave the stock Buy rating on February 20, 2024, issuing a price target of $50- $54. Piper Sandler on their part issued Overweight rating on February 13, 2024.
